SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-22-001862
Filing Date
2022-02-18
Accepted
2022-02-18 19:05:39
Documents
1
Period of Report
2022-02-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1366
  Complete submission text file 0001654954-22-001862.txt   3019
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2355 MAIN STREET SUITE 120 IRVINE CA 92614
Business Address
Ohri Manu (Reporting) CIK: 0001424683 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 22654471